IT1155438B - Uso di peptidi come medicamenti - Google Patents
Uso di peptidi come medicamentiInfo
- Publication number
- IT1155438B IT1155438B IT24915/82A IT2491582A IT1155438B IT 1155438 B IT1155438 B IT 1155438B IT 24915/82 A IT24915/82 A IT 24915/82A IT 2491582 A IT2491582 A IT 2491582A IT 1155438 B IT1155438 B IT 1155438B
- Authority
- IT
- Italy
- Prior art keywords
- medications
- peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK576381 | 1981-12-23 |
Publications (3)
Publication Number | Publication Date |
---|---|
IT8224915A0 IT8224915A0 (it) | 1982-12-22 |
IT8224915A1 IT8224915A1 (it) | 1984-06-22 |
IT1155438B true IT1155438B (it) | 1987-01-28 |
Family
ID=8145055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT24915/82A IT1155438B (it) | 1981-12-23 | 1982-12-22 | Uso di peptidi come medicamenti |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0082731A1 (it) |
JP (1) | JPS58116421A (it) |
AU (1) | AU9188382A (it) |
BE (1) | BE895432A (it) |
DE (1) | DE3247786A1 (it) |
GB (1) | GB2112641A (it) |
GR (1) | GR78411B (it) |
IT (1) | IT1155438B (it) |
LU (1) | LU84546A1 (it) |
NZ (1) | NZ202757A (it) |
ZA (1) | ZA829408B (it) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6849708B1 (en) | 1986-05-05 | 2005-02-01 | The General Hospital Corporation | Insulinotropic hormone and uses thereof |
US5614492A (en) * | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof |
US5120712A (en) * | 1986-05-05 | 1992-06-09 | The General Hospital Corporation | Insulinotropic hormone |
EP1498425A1 (en) * | 1986-05-05 | 2005-01-19 | The General Hospital Corporation | Use of glucagone-like-peptide 1 (GLP-1) derivatives for the preparation of pharmaceutical compositions |
US7138486B2 (en) | 1986-05-05 | 2006-11-21 | The General Hospital Corporation | Insulinotropic hormone derivatives and uses thereof |
GB9409496D0 (en) | 1994-05-12 | 1994-06-29 | London Health Ass | Method for improving glycaemic control in diabetes |
US5574008A (en) * | 1994-08-30 | 1996-11-12 | Eli Lilly And Company | Biologically active fragments of glucagon-like insulinotropic peptide |
US5512549A (en) * | 1994-10-18 | 1996-04-30 | Eli Lilly And Company | Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
DK2158214T3 (da) | 2007-06-15 | 2011-12-05 | Zealand Pharma As | Glukagonanaloger |
EP2025684A1 (en) * | 2007-08-15 | 2009-02-18 | Zealand Pharma A/S | Glucagon analogues |
CN102282167B (zh) | 2008-12-15 | 2014-08-13 | 西兰制药公司 | 胰高血糖素类似物 |
DK2370462T3 (da) | 2008-12-15 | 2014-09-08 | Zealand Pharma As | Glucagon-analoger |
JP5635530B2 (ja) | 2008-12-15 | 2014-12-03 | ジーランド ファーマ アクティーゼルスカブ | グルカゴン類似体 |
DK2370461T3 (da) | 2008-12-15 | 2013-12-16 | Zealand Pharma As | Glucagonanaloger |
US9156901B2 (en) | 2009-07-13 | 2015-10-13 | Ditte Riber | Acylated glucagon analogues |
UY33462A (es) | 2010-06-23 | 2012-01-31 | Zealand Pharma As | Analogos de glucagon |
PE20130338A1 (es) | 2010-06-24 | 2013-03-16 | Zealand Pharma As | Analogos del glucagon |
SG11201407137PA (en) | 2012-05-03 | 2014-11-27 | Zealand Pharma As | Gip-glp-1 dual agonist compounds and methods |
MX356957B (es) | 2012-07-23 | 2018-06-20 | Zealand Pharma As | Analogos del glucagon. |
TWI608013B (zh) | 2012-09-17 | 2017-12-11 | 西蘭製藥公司 | 升糖素類似物 |
US9988429B2 (en) | 2013-10-17 | 2018-06-05 | Zealand Pharma A/S | Glucagon analogues |
MX368436B (es) | 2013-10-17 | 2019-10-03 | Zealand Pharma As | Analogos de glucagon acilados. |
EP3065767B1 (en) | 2013-11-06 | 2020-12-30 | Zealand Pharma A/S | Gip-glp-1 dual agonist compounds and methods |
WO2015067716A1 (en) | 2013-11-06 | 2015-05-14 | Zealand Pharma A/S | Glucagon-glp-1-gip triple agonist compounds |
AU2015340586B2 (en) | 2014-10-29 | 2020-04-30 | Zealand Pharma A/S | GIP agonist compounds and methods |
BR112017022009A2 (pt) | 2015-04-16 | 2018-07-03 | Zealand Pharma A/S | ?composto, método de produção e síntese do mesmo e seu uso, composição e conjunto terapêutico? |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK283180A (da) * | 1980-07-01 | 1982-01-02 | Novo Industri As | Polypeptider og derivater deraf |
-
1982
- 1982-12-09 NZ NZ202757A patent/NZ202757A/en unknown
- 1982-12-21 BE BE6/47758A patent/BE895432A/fr not_active IP Right Cessation
- 1982-12-22 JP JP57225755A patent/JPS58116421A/ja active Pending
- 1982-12-22 EP EP82306879A patent/EP0082731A1/en not_active Withdrawn
- 1982-12-22 ZA ZA829408A patent/ZA829408B/xx unknown
- 1982-12-22 IT IT24915/82A patent/IT1155438B/it active
- 1982-12-22 GB GB08236403A patent/GB2112641A/en not_active Withdrawn
- 1982-12-22 GR GR70154A patent/GR78411B/el unknown
- 1982-12-22 LU LU84546A patent/LU84546A1/de unknown
- 1982-12-23 DE DE19823247786 patent/DE3247786A1/de not_active Withdrawn
- 1982-12-23 AU AU91883/82A patent/AU9188382A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE3247786A1 (de) | 1983-07-21 |
NZ202757A (en) | 1985-11-08 |
GB2112641A (en) | 1983-07-27 |
JPS58116421A (ja) | 1983-07-11 |
EP0082731A1 (en) | 1983-06-29 |
ZA829408B (en) | 1983-10-26 |
BE895432A (fr) | 1983-06-21 |
IT8224915A1 (it) | 1984-06-22 |
GR78411B (it) | 1984-09-27 |
AU9188382A (en) | 1983-06-30 |
LU84546A1 (de) | 1983-09-08 |
IT8224915A0 (it) | 1982-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1155438B (it) | Uso di peptidi come medicamenti | |
DE3278402D1 (de) | Ultrapurificated factor viii : c preparation | |
NO823019L (no) | Sjampo | |
KR830002307U (ko) | 화장품 케이스 | |
IT1152342B (it) | Siringa | |
DK345682A (da) | Pharmaceutiske expienser | |
KR840000084U (ko) | 화장품 케이스 | |
FI833706A0 (fi) | Peptider | |
SE8302766D0 (sv) | Packningselement | |
IT1158049B (it) | Cefalosporine-betaine di isochinolinio | |
IT8248677A0 (it) | Formulazioni farmaceutiche | |
DK152219C (da) | Azopigmentpraeparater | |
DK288686D0 (da) | Farmaceutiske praeparater | |
DK354487A (da) | Oncogen-relaterede peptider | |
FI831687A0 (fi) | Farmaceutiska blandningar vilka innehaoller flere aktiva bestaondsdelar | |
IT8322114A0 (it) | Composti di peptidi sostituiti. | |
DK314283A (da) | Farmaceutiske praeparater | |
IT1156108B (it) | Alchilamidi di carbossialcanoil peptidi | |
DK49686D0 (da) | Antigeniske peptider | |
IT1173654B (it) | Impiego di colecalciferol-derivati | |
DK435382A (da) | Praeparater med langvarig frigoerelse | |
IT1208432B (it) | Composizioni farmaceutiche | |
IT8249072A0 (it) | Composizioni farmaceutiche | |
IT8321128A0 (it) | Impiego di uncolecalciferolderivato. | |
IT1198416B (it) | Procedimento di preparazione di mononitroclorobenzene |